Target Price | €51.20 |
Price | €38.35 |
Potential |
33.51%
register free of charge
|
Number of Estimates | 5 |
5 Analysts have issued a price target Dermapharm 2026 .
The average Dermapharm target price is €51.20.
This is
33.51%
register free of charge
€70.00
82.53%
register free of charge
€44.00
14.73%
register free of charge
|
|
A rating was issued by 5 analysts: 5 Analysts recommend Dermapharm to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Dermapharm stock has an average upside potential 2026 of
33.51%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion € | 1.18 | 1.20 |
4.00% | 1.22% | |
EBITDA Margin | 25.23% | 27.48% |
6.07% | 8.93% | |
Net Margin | 9.62% | 10.60% |
74.90% | 10.18% |
5 Analysts have issued a sales forecast Dermapharm 2025 . The average Dermapharm sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Dermapharm EBITDA forecast 2025. The average Dermapharm EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Dermapharm Analysts have issued a net profit forecast 2025. The average Dermapharm net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share € | 2.11 | 2.35 |
81.90% | 11.37% | |
P/E | 16.30 | |
EV/Sales | 2.45 |
4 Analysts have issued a Dermapharm forecast for earnings per share. The average Dermapharm EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
BERENBERG |
Locked
➜
Locked
|
Locked | Apr 07 2025 |
ODDO BHF |
Locked
➜
Locked
|
Locked | Apr 02 2025 |
MWB RESEARCH AG |
Locked
➜
Locked
|
Locked | Mar 30 2025 |
JEFFERIES |
Locked
➜
Locked
|
Locked | Mar 13 2025 |
BERENBERG |
Locked
➜
Locked
|
Locked | Dec 08 2024 |
MWB RESEARCH AG |
Locked
➜
Locked
|
Locked | Nov 14 2024 |
ODDO BHF |
Locked
➜
Locked
|
Locked | Nov 14 2024 |
Analyst Rating | Date |
---|---|
Locked
BERENBERG:
Locked
➜
Locked
|
Apr 07 2025 |
Locked
ODDO BHF:
Locked
➜
Locked
|
Apr 02 2025 |
Locked
MWB RESEARCH AG:
Locked
➜
Locked
|
Mar 30 2025 |
Locked
JEFFERIES:
Locked
➜
Locked
|
Mar 13 2025 |
Locked
BERENBERG:
Locked
➜
Locked
|
Dec 08 2024 |
Locked
MWB RESEARCH AG:
Locked
➜
Locked
|
Nov 14 2024 |
Locked
ODDO BHF:
Locked
➜
Locked
|
Nov 14 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.